PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Understanding the Impact of Gene Fusion Detection in NSCLC: The Latest Updates on Testing and Treatment Strategies
Visit https://www.peervoice.com/PUS860 to view the entire programme with slides. After completing “Understanding the Impact of Gene Fusion Detection in NSCLC: The Latest Updates on Testing and Treatment Strategies”, participants will be able to: Explain how adeno-associated virus (AAV)–based gene therapy is revolutionising medicine; Differentiate between in vivo and ex vivo gene therapies; Summarise the key features of a condition/disorder that could make it suitable for an AAV-based gene therapy approach; Discuss the key ethical issues surrounding gene therapy; Describe the differences in the safety profile of non-integrating vs integrating gene therapy vectors; Identify the conditions/disorders where there are ongoing clinical trials with AAV-based gene therapies.